| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |